Jakks Pacific (JAKK) Tops Q3 Earnings and Revenue Estimates
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Oct 30 2024
0mins
Source: NASDAQ.COM
Earnings Performance: Jakks Pacific reported quarterly earnings of $4.79 per share, exceeding expectations and showing a slight increase from the previous year, but has struggled overall with only one earnings surprise in the last four quarters.
Stock Outlook: The company's stock is currently rated Zacks Rank #4 (Sell) due to unfavorable estimate revisions, indicating it may underperform the market in the near future, while the Toys - Games - Hobbies industry remains relatively strong.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy TTWO?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on TTWO
Wall Street analysts forecast TTWO stock price to rise
14 Analyst Rating
14 Buy
0 Hold
0 Sell
Strong Buy
Current: 220.670
Low
270.00
Averages
286.77
High
300.00
Current: 220.670
Low
270.00
Averages
286.77
High
300.00
About TTWO
Take-Two Interactive Software, Inc. is a developer, publisher, and marketer of interactive entertainment for consumers around the globe. The Company develops and publishes products principally through Rockstar Games, 2K, and Zynga. Its products are designed for console gaming systems, including, but not limited to, the Sony Computer Entertainment, Inc. (Sony) PlayStation4 (PS4) and PlayStation5 (PS5), the Microsoft Corporation (Microsoft) Xbox One (Xbox One) and Xbox Series XS (Xbox Series XS), and the Nintendo Switch (Switch), as well as mobile, including smartphones and tablets, and personal computers (PC). It delivers its products through physical retail, digital download, online platforms, and cloud streaming services. It sells software titles both digitally and physically through direct relationships with digital storefronts and platform partners, large retail customers, and third-party distributors. It also sells advertising within a number of its games, primarily in mobile.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Market Opportunity Analysis: UBS believes that meaningful investment opportunities still exist despite stocks nearing all-time highs, particularly in companies like Broadcom and Accenture, reflecting optimism for future growth.
- Broadcom's Strong Performance: Broadcom's stock has risen 22% this year, with a forecasted cash flow return on investment (CFROI) exceeding 80% by 2027, indicating its leadership in ASIC chips and the importance of AI workloads, suggesting robust future performance.
- Accenture Facing Challenges: Although Accenture's CFROI is projected to reach 43.7%, its stock has fallen 34% this year, reflecting market concerns over margin pressure and disintermediation risks from emerging AI models, leading to subdued investor sentiment.
- Investment Strategy Recommendations: UBS advises investors to focus on companies with improving cash flow returns and high-quality laggards, emphasizing the potential value of these firms in the software and IT consulting sectors, despite their stock prices having declined by over 5%.
See More
- Industry Impact: Take-Two CEO Strauss Zelnick stated that the successful launch of GTA VI will energize the entire entertainment market, expected to drive consumer spending and enhance both company and industry performance.
- Financial Outlook: The company anticipates FY2027 net bookings between $8.0 billion and $8.2 billion, representing approximately 20% growth, while also expecting operating cash flow to exceed $1.0 billion, indicating a strong financial foundation and future growth potential.
- Market Performance: In FY2026, Take-Two's net bookings rose 19% to $6.72 billion, surpassing initial guidance by $750 million, demonstrating robust performance across multiple brands and reducing pre-launch execution risks for GTA VI.
- Long-Term Growth Potential: With a pipeline of 29 new game titles, Take-Two is positioned for sustained revenue growth, particularly following the launch of GTA VI, which is expected to enhance the company's long-term profitability.
See More
- Revenue Performance: Take-Two reported Q1 CY2026 revenue of $1.58 billion, exceeding analyst expectations of $1.56 billion, indicating stability in its core business despite flat year-over-year sales.
- Earnings Beat: The GAAP loss per share was $0.32, outperforming analyst estimates of a $0.52 loss by 38.4%, reflecting improvements in cost control and operational efficiency.
- Cautious Future Outlook: The revenue guidance for Q2 is set at $1.48 billion, below the $1.54 billion expected by analysts, highlighting management's cautious stance on the mature mobile gaming market, although the upcoming launch of Grand Theft Auto VI is anticipated to drive revenue growth.
- Direct-to-Consumer Progress: By integrating more mobile titles into its direct-to-consumer platform, Take-Two achieved higher margins and customer loyalty, with management believing this trend will continue despite challenges posed by a changing market landscape.
See More
- Market Recovery: The S&P 500 rose by 0.37% and the Nasdaq 100 by 0.42%, with the Dow Jones Industrial Average hitting an all-time high, reflecting optimism about a potential US-Iran peace deal that could boost investor confidence.
- Consumer Sentiment Decline: The University of Michigan's consumer sentiment index was revised down to a record low of 44.8, below the expected 48.2, indicating growing concerns among consumers about the economic outlook, which may impact future spending.
- Rising Inflation Expectations: The 1-year inflation expectations for May were revised upward to 4.8%, exceeding the expected 4.6%, potentially prompting the Federal Reserve to consider interest rate hikes in upcoming meetings, which could pressure the stock market.
- Tech Stocks Lead Gains: Workday's stock surged over 5% after reporting Q1 adjusted EPS of $2.66, surpassing expectations, highlighting strong performance in the software sector and potentially attracting more investor interest in tech stocks.
See More
- Strong Market Performance: The S&P 500 rose by 0.50% and the Nasdaq 100 by 0.73%, with the Dow Jones Industrial Average hitting an all-time high, reflecting optimism about a potential US-Iran peace deal that could boost investor confidence.
- Decline in Consumer Confidence: The University of Michigan's consumer sentiment index was revised down to 44.8, a record low, below the expected 48.2, indicating growing consumer concerns about the economic outlook, which may negatively impact future spending.
- Rising Inflation Expectations: The 1-year inflation expectations for May were revised up to 4.8%, a 9-month high, exceeding the expected 4.6%, which could prompt the Fed to consider interest rate hikes at the upcoming meeting, affecting market liquidity.
- Chip Stocks Lead Gains: Qualcomm's stock surged over 12%, leading the Nasdaq 100, demonstrating ongoing market enthusiasm for semiconductor and AI infrastructure, which may yield higher returns for related companies.
See More
- Lenovo's Performance Boost: Lenovo reported an 84% increase in AI-related revenue for Q4, leading to a nearly 20% surge in its stock price, which also propelled Dell and HP shares up over 15%, reflecting strong market demand and competitive positioning in AI technology.
- Estee Lauder's Stock Recovery: Estee Lauder's shares rose 10% despite ending merger talks with Puig, indicating robust market performance and a solid position in the cosmetics industry.
- Workday's Strong Results: Workday's stock jumped nearly 4% after posting better-than-expected earnings and raising its full-year margin outlook, showcasing its growth potential in finance and HR software.
- Merck's Drug Breakthrough: Merck's lung cancer treatment, developed in partnership with Kelun-Biotech, demonstrated a 65% reduction in tumor progression risk in a phase 3 study, resulting in a nearly 5% increase in stock price, reinforcing its competitive edge in oncology.
See More











